Oral fixed drug eruptions to mefenamic acid - adverse drug reaction to over the counter medication taken for menstrual pain

Authors

  • Santosh Palla Consultant, Oral Medicine and Radiology, Sun Dental Care, Tondiarpet, Chennai, Tamil Nadu- 600081, India. https://orcid.org/0000-0002-3713-5238
  • Sajan Anand G Senior Lecturer, Oral and Maxillofcail Surgery, KIMS Dental College and Hospital, NH-216, Chaitanya Health city, Amalapuram, E.G. Dist, A.P.- 533201, India
  • Vijayparthiban Sethuraman Department of Dental Surgery, Thanjavur Medical College, Dr. M.G.R. Medical University, Tamil Nadu- 613004, India

DOI:

https://doi.org/10.15386/mpr-2325

Keywords:

adverse drug reaction, fixed drug eruptions, mefenamic acid, oral cavity, over the counter medication, menstrual pain

Abstract

The reports on adverse drug reactions(ADR) to self-medication or over-the-counter medication are common across medical literature. However, the occurrence of oral fixed drug eruptions (FDE) to mefenamic acid is unique. We report a case of FDE to a drug obtained over the counter for menstrual pain. The essential findings from history, oral/ dental examination, diagnostic approach, and treatment are briefly discussed along with a note on time and dosing for the oral drug provocation tests. The occurrence of ADR may be avoided by spreading awareness against OTC medication and labeling the specific drug for patients with established ADR.

Downloads

Published

2022-06-24

How to Cite

1.
Palla S, G SA, Sethuraman V. Oral fixed drug eruptions to mefenamic acid - adverse drug reaction to over the counter medication taken for menstrual pain. Medicine and Pharmacy Reports [Internet]. 2022 Jun. 24 [cited 2025 May 22];95(3):348-51. Available from: https://medpharmareports.com/index.php/mpr/article/view/2325

Issue

Vol. 95 No. 3 (2022)

Section

Case Report

License

The authors are required to transfer the copyright of the published paper to the journal. This is done by agreeing to sign the Copyright Assignment Form. Whenever the case, authors are also required to send permissions to reproduce material (such as illustrations) from the copyright holder.

 Creative Commons License
The papers published in the journal are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.